Tracy M. Woody

Chief Commercial Officer, ZEVRA THERAPEUTICS, INC.

Companies

Esperion TherapeuticsBoard member May 31, 2019 to now¹
Aravive, Inc.Chief Commercial Officer Mar 31, 2017 to Mar 26, 2018²
ZEVRA THERAPEUTICS, INC.Chief Commercial Officer Apr 15, 2015 to Feb 16, 2016³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Esperion Therapeutics ESPR33,566 shares⁴Jun 15, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Jun 15, 2023Granted 5,150 shares of Esperion Therapeutics⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGAREsperion Therapeutics, Board member
2
SEC EDGARAravive, Inc., Chief Commercial Officer
3
SEC EDGARZEVRA THERAPEUTICS, INC., Chief Commercial Officer
4
SEC EDGAREsperion Therapeutics shares after the filing of Jun 15, 2023